Publications
5543 Results
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 16; abstr 9035); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
- Year
- 2023
- Research Committee(s)
- Lung
- Study Number(s)
- LUNGMAP
The effect of ctDNA Tumor Fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 16; abstr TPS9143); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), tip, poster session
- Year
- 2023
- Research Committee(s)
- Lung
- Study Number(s)
- S1900E
ECOG-ACRIN LUNG-MAP S1900E Substudy (NCT04625647): A Phase II Study of Sotorasib in Participants (Pts) With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous (Non-sq) Non-Small Cell Lung Cancer (NSCLC)
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 16; abstr 8504); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), oral
- Year
- 2023
- Research Committee(s)
- Lung
- Study Number(s)
- S1929
SWOG S1929: Phase II Randomized Study of Maintenance Atezolizumab (A) Versus Atezolizumab + Talazoparib (AT) in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- Journal / Conference
- J Clin Oncol 41, 2023 (suppl 16; abstr 12003); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), oral
- Year
- 2023
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1714
Chemotherapy Induced Peripheral Neuropathy (CIPN) due to Paclitaxel versus Docetaxel in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)
- Journal / Conference
- NPJ Breast Cancer May 13;9(1):38
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37179362
- PMC
- PMC10182981
- Study Number(s)
- S0800
Image analysis-based tumor infiltrating lymphocyte measurement predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer (SWOG S0800)
- Journal / Conference
- JNCI Cancer Spectrum May 2;7(3):pkad030
- Year
- 2023
- PMID
- PMID37104744
- PMC
- PMC10208111
Feasibility and Acceptability of an Online Intervention to Enhance Hopefulness Among Oncology Professionals
- Journal / Conference
- JAMA Network Open May 1;6(5):e2311673
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37140922
- PMC
- PMC10160875
- Study Number(s)
- S0221
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
- Journal / Conference
- JAMA Oncology Aug 1;9(8):1083-1089
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID37410451
- PMC
- PMC10326730
- Study Number(s)
- S1007
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients with Favorable-Risk Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial
- Journal / Conference
- Nature Medicine Jun;29(6):1412-1423
- Year
- 2023
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID37264206
- PMC
- PMC10287565
- Study Number(s)
- S0000, SWOG-9217
Genetically Adjusted PSA Levels for Prostate Cancer Screening
- Journal / Conference
- JCO Oncology Practice Aug;19(8):533-535
- Year
- 2023
- PMID
- PMID37285550
- PMC
- PMC10424897